Cisen Pharmaceutical Co Ltd (603367) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.050x

Based on the latest financial reports, Cisen Pharmaceutical Co Ltd (603367) has a cash flow conversion efficiency ratio of 0.050x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥311.93 Million ≈ $45.64 Million USD) by net assets (CN¥6.19 Billion ≈ $906.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 603367 days of operational coverage to measure how many days the company can operate on defensive assets alone.

Cisen Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Cisen Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Cisen Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cisen Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
SG Fleet Group Ltd AU:SGF	-0.064x
JOST Werke AG XETRA:JST	0.081x
uPI Semiconductor Corp TW:6719	0.020x
BW Offshore Ltd OL:BWO	0.266x
Shandong Xinhua Pharmaceutical Co Ltd SHE:000756	0.010x
Fujian Longma Envi Sanitation SHG:603686	0.030x
Center Laboratories TWO:4123	0.002x
Gryphon Capital Income Trust AU:GCI	-0.161x

Annual Cash Flow Conversion Efficiency for Cisen Pharmaceutical Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Cisen Pharmaceutical Co Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see Cisen Pharmaceutical Co Ltd market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥6.23 Billion ≈ $911.75 Million	CN¥466.37 Million ≈ $68.25 Million	0.075x	-21.50%
2024-12-31	CN¥5.99 Billion ≈ $876.08 Million	CN¥570.85 Million ≈ $83.53 Million	0.095x	+21.85%
2023-12-31	CN¥5.77 Billion ≈ $843.81 Million	CN¥451.24 Million ≈ $66.03 Million	0.078x	+62.23%
2022-12-31	CN¥5.36 Billion ≈ $783.73 Million	CN¥258.35 Million ≈ $37.80 Million	0.048x	+4.39%
2021-12-31	CN¥5.06 Billion ≈ $739.79 Million	CN¥233.60 Million ≈ $34.18 Million	0.046x	-48.52%
2020-12-31	CN¥4.80 Billion ≈ $702.68 Million	CN¥431.01 Million ≈ $63.07 Million	0.090x	+126.48%
2019-12-31	CN¥4.57 Billion ≈ $669.29 Million	CN¥181.26 Million ≈ $26.52 Million	0.040x	-59.51%
2018-12-31	CN¥4.15 Billion ≈ $608.01 Million	CN¥406.68 Million ≈ $59.51 Million	0.098x	-17.08%
2017-12-31	CN¥3.72 Billion ≈ $544.98 Million	CN¥439.61 Million ≈ $64.33 Million	0.118x	-7.08%
2016-12-31	CN¥2.30 Billion ≈ $336.34 Million	CN¥291.97 Million ≈ $42.72 Million	0.127x	+0.13%
2015-12-31	CN¥2.10 Billion ≈ $307.11 Million	CN¥266.24 Million ≈ $38.96 Million	0.127x	+775.81%
2014-12-31	CN¥1.90 Billion ≈ $278.19 Million	CN¥27.54 Million ≈ $4.03 Million	0.014x	-69.23%
2013-12-31	CN¥1.73 Billion ≈ $252.63 Million	CN¥81.26 Million ≈ $11.89 Million	0.047x	+125.43%
2012-12-31	CN¥1.58 Billion ≈ $231.88 Million	CN¥33.09 Million ≈ $4.84 Million	0.021x	-63.20%
2011-12-31	CN¥1.34 Billion ≈ $196.74 Million	CN¥76.28 Million ≈ $11.16 Million	0.057x	--

About Cisen Pharmaceutical Co Ltd

SHG:603367 China Drug Manufacturers - Specialty & Generic

Market Cap

$865.25 Million

CN¥5.91 Billion CNY

Market Cap Rank

#9712 Global

#2571 in China

Share Price

CN¥13.06

Change (1 day)

+0.54%

52-Week Range

CN¥12.99 - CN¥34.05

All Time High

CN¥34.05